Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), a powerful compound produced endogenously by Sonoran Desert toad venom, to treat depression. The Series B financing was initially set at $50 million—but was upgraded… Keep Reading
Medical cannabis access continues to grow across the United States. However access remains a problem for patients traveling outside their home state. Today, 33 states and Washington, D.C. have legalized medical cannabis marketplaces and/or have similar regulations in place. July 2019 numbers from the Marijuana Policy Project estimate that just under 3.1 million patients are… Keep Reading
On November 1, 2018 the United Kingdom legalized medical marijuana treatments and hemp CBD products. This new market opens the door to a multitude of business opportunities and many people didn’t waste any time and immediately jumped on the green wave. Two hours away from London and only a few blocks away from the sea,… Keep Reading
Dabs getting you higher than joints is not a new concept in the United States. In fact, they rose to popularity in the US when headlines touted their potency with unsubstantiated claims that one dab was as strong as five joints. While the act of consuming concentrates has become common among American cannabis users, hardly… Keep Reading
